Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +34.74%
#2 Cortex Cortex +32.63%
#3 DexNet DexNet +23.20%
#4 wojak wojak +21.48%
#5 Akedo Akedo +20.54%
#6 Pons Pons +18.91%
#7 SODAX SODAX +17.42%
#8 APEX APEX +13.93%
#9 ETHGas ETHGas +13.11%
#10 OpenEden OpenEden +12.21%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
設定
言語
日本
通貨
USD
テーマ
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
株式のランク #7141
Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical... Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.
株価
$40.39
最終同期: 2023-08-18
時価総額
$1.70B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Chinook Therapeutics, Inc. (KDNY)

カテゴリー

Healthcare
Chinook Therapeutics, Inc.（KDNY）の配当履歴
Chinook Therapeutics, Inc.（証券コード：KDNY）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのChinook Therapeutics, Inc.（KDNY）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH